Next generation therapies


Next generation therapies

Transitioning healthcare from treatment to cure

Deloitte has invested heavily in this space, with a Next Generation (NextGen) Therapies practice that has been involved in every large transaction in this space with either M&A due diligence, commercial due diligence, valuation/modeling or strategy.

Deloitte’s Global Life Sciences and Health Care team has released a new presentation specifically on the growing NextGen Therapies industry, including its exponential growth in the US and China. In it, we identify key opportunities for organizations to get involved in this revolutionary moment in healthcare history.

Please contact us if you would like to discuss this space and the related trends and opportunities. Amit Agarwal and our other Global Life Sciences and Health Care leaders will be available to meet live at the 2020 J.P. Morgan Health Care Investor Conference, January 13-16 in San Francisco. Register to meet with them as well as participate in our other events.

Did you find this useful?